NBS Board of Directors

Owen A. O’Connor, M.D., Ph.D. | Chairman & Chief Executive Officer
-
American Cancer Society Research Physician
-
25 years leading translational research programs in academic medicine at premier cancer centers in US;
-
Over 25+ inventions filed in US and Ex-US;
-
8 drugs approved across 50 countries;
-
Experience as Chief Scientific Officer overseeing approvals of drugs in B-cell lymphoma, autoimmune D/O & pipeline development, including umbralisib and ublituximab.

Mark Lerner, Esq. | Member
-
Co-Chair of Kasowitz Benson & Torres Employment Practice and Litigation group
-
Former Federal Prosecutor
-
Has Represented Major Hospitals and Oncologists in Wide Range of Matters
-
Experience with Regulators Across the Government and Multiple Industries
-
Recognized by Chambers USA, The Legal 500 and Benchmark Litigation as a top Labor and Employment Law practitioner.

Andrew Pecora, M.D., FACP, CPE | Member
-
A nationally recognized expert in healthcare discovery, business and delivery, Dr. Pecora, is at the forefront of the health-systems improvement movement.
-
A certified hematologist and oncologist – and one of the world's leading experts in blood and marrow stem cell transplantation, cellular medicine and immunology research – He has played a pivotal role in innovative research and clinical trials, expansion of patient care services and introduction of new, state-of-the-art technologies to shift administrative burdens from healthcare professionals.
-
Dr. Pecora is a national advocate for making medical practices more efficient and profitable, and at the same time, improving patient care.
-
He is dedicated to pairing practices with artificial intelligence (AI) and health technologies to increase efficiencies, reduce costs and enable physicians to better do what they do best – heal patients.
-
He holds over 70 patents in life science and information technology.